{"url_path":"/sec/dare/8-k/2026-05-14/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1401914/0001401914-26-000025-index.html","accession_number":"0001401914-26-000025","cik":"0001401914","ticker":"DARE","issuer_name":"Dare Bioscience, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1401914/0001401914-26-000025-index.html","primary_entity_key":"0001401914","primary_entity_name":"Dare Bioscience, Inc."},"word_count":81,"has_tables":true,"body_markdown":"Item 9.01Financial Statements and Exhibits.\n\n(d) Exhibits.\n\nExhibit No.Description\n\n99.1\n[Press release issued on May 14, 2026](a260514q12026earningsupd.htm)\n\n104Cover Page Interactive Data File (embedded within the Inline XBRL document)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n  \nDARÉ BIOSCIENCE, INC.\n\n \n\nDated: May 14, 2026  By: /s/ Sabrina Martucci Johnson\n\n  Name: Sabrina Martucci Johnson\n\n  Title: President and Chief Executive Officer"}